With consistent use, they deliver visible, lasting anti-aging results without irritation.
FDA scientists push back on RFK Jr.'s peptide plans, longevity investment eyes a record year, and Hevolution expands its research bench Three stories our co-hosts Klaudia Balogh and Elias Arjan broke down on this week's episode: a regulatory standoff over peptides, fresh data on where longevity capital is flowing in 2026, and a grant program that Elias calls a smarter funding model than most of Silicon Valley's
Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown. Theres almost zero basically zero evidence in human trials, Spittler said
Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction
Toxicity from B12-derived cyanide has never been documented even with mega-dose supplementation
The cumulative antioxidant activity could be very high with the reactivation of the carboxylic groups (e.g., glutathione or enzymes)